Cardiovascular
The circulatory system is a vast network of organs and vessels that is responsible for the flow of blood, nutrients, oxygen and other gases, and hormones to and from cells. The system consists of three independent systems that work together: the heart (cardiovascular), lungs (pulmonary), and arteries, veins, coronary and portal vessels (systemic). Together, the heart, blood, and blood vessels make up the cardiovascular component of the circulatory system. It includes the pulmonary circulation, a "loop" through the lungs where blood is oxygenated. It also incorporates the systemic circulation, which runs through the rest of the body to provide oxygenated blood.
Because of its vastness and critical nature, the circulatory system is one of the systems of the body most prone to disease. Disorders of this system are the leading cause of death among adults in the majority of countries world-wide, arteriosclerosis being one of the most common diseases. It is characterized by fatty deposits in the arteries that cause the walls to stiffen and thicken the walls, and may result in restricted blood flow and ischemia. This may result in symptoms such as angina and dyspnea, necrosis, and ultimately in heart attack or stroke. Hypertension, another circulatory is disease, causes the heart to work harder and can lead to complications as a heart attack, a stroke, or kidney failure. Abnormal blood lipid levels, that is high total cholesterol, high levels of triglycerides, high levels of low-density lipoprotein or low levels of high-density lipoprotein (HDL) cholesterol all increase the risk of heart disease and stroke, and are of particular interest of modern research. Besides changing food intake habits of patients suffering from cardiovascular diseases, in combination with the stimulation to increase physical exercise, special medication may also modify a patients blood lipid profile and prevent the person from developing life threatening circulatory diseases.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
2022 | Zoniporide hydrochloride | Inhibitor of Na+/H+ exchanger isoform 1 (NHE-1) | €90.00 | |
4001 | ZM241385 | Potent and selective adenosine A2A antagonist | €110.00 | |
2878 | ZL006 | Selective inhibitor of the nNOS-PSD-95 interaction | €105.00 | |
3596 | ZG-2033 | Potent and orally bioavailable HIF-2α agonist | €130.00 | |
2261 | ZD 9379 | Antagonist of the glycine site on the NMDA receptor complex | €95.00 | |
2543 | ZCZ 011 | Brain penetrant CB1 positive allosteric modulator (PAM) | €90.00 | |
1248 | Zatebradine hydrochloride | HCN channel blocker | €110.00 | |
1216 | Zardaverine | PDE3 and PDE4 inhibitor | €80.00 | |
1273 | Zamifenacin fumarate | Muscarinic M3 antagonist | €130.00 | |
1685 | YS 49 | Antiplatelet, antithrombotic | €135.00 | |
3604 | YM-244769 dihydrochloride | Highly potent inhibitor of reverse Na+/Ca2+ exchanger (NCX) activity | €90.00 | |
1305 | XE 991 dihydrochloride | KCNQ channel and M-current blocker | €90.00 | |
1987 | XE 991 | KCNQ channel and M-current blocker | €90.00 | |
3265 | XAF-1407 | Potent and highly selective IKACh inhibitor | €140.00 | |
2896 | WNK Inhibitor 11 | Selective allosteric inhibitor of WNK1 | €140.00 | |
1804 | Wiskostatin | Inhibitor of neural Wiskott-Aldrich syndrome protein (N-WASP) | €105.00 | |
2325 | WAY 316606 hydrochloride | Potent inhibitor of sFRP-1 that stimulates Wnt signaling | €85.00 | |
3799 | VU6036721 hydrochloride | Inactive enantiomer of VU6036720 hydrochloride | €130.00 | |
3675 | VU6036720 hydrochloride | First potent and selective inhibitor of heteromeric Kir4.1/5.1 inward rectifier potassium channels | €130.00 | |
3593 | VU0468554 | Selective cardiac GIRK inhibitor | €110.00 | |
4088 | Voxelotor | First-in-class, potent and orally bioavailable allosteric HbS effector | €90.00 | |
2938 | Verinurad | Highly potent and selective inhibitor of the renal urate transporter URAT1 | €95.00 | |
3558 | Vericiguat | Potent and orally available sGC stimulator | €140.00 | |
3452 | Verapamil hydrochloride | Ca2+ channel antagonist | €50.00 | |
1608 | VER 155008 | Hsp70 inhibitor | €95.00 | |
1867 | Vasopressin antagonist 1867 | Orally available and selective V1b receptor antagonist | €150.00 | |
3396 | Vardenafil dihydrochloride | Highly potent, selective and orally bioavailable inhibitor of cGMP-specific PDE5 | €60.00 | |
3106 | Valsartan | Potent, highly selective, and orally active AT1 antagonist | €76.00 | |
2581 | UR 1102 | Selective inhibitor of the renal urate transporter URAT1 | €110.00 | |
2369 | UPF 1069 | PARP-2 inhibitor with >26 fold selectivity over PARP1 | €75.00 |